IT201600130012A1 - Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale - Google Patents

Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale

Info

Publication number
IT201600130012A1
IT201600130012A1 IT102016000130012A IT201600130012A IT201600130012A1 IT 201600130012 A1 IT201600130012 A1 IT 201600130012A1 IT 102016000130012 A IT102016000130012 A IT 102016000130012A IT 201600130012 A IT201600130012 A IT 201600130012A IT 201600130012 A1 IT201600130012 A1 IT 201600130012A1
Authority
IT
Italy
Prior art keywords
disorders
treatment
composition
urogenital system
urogenital
Prior art date
Application number
IT102016000130012A
Other languages
English (en)
Inventor
Maio Umberto Di
Antonino Bagnulo
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102016000130012A priority Critical patent/IT201600130012A1/it
Priority to EP17832350.7A priority patent/EP3558459A1/en
Priority to RU2019122801A priority patent/RU2019122801A/ru
Priority to PCT/IB2017/058284 priority patent/WO2018116238A1/en
Priority to CN201780086737.1A priority patent/CN110300616A/zh
Publication of IT201600130012A1 publication Critical patent/IT201600130012A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT102016000130012A 2016-12-22 2016-12-22 Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale IT201600130012A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT102016000130012A IT201600130012A1 (it) 2016-12-22 2016-12-22 Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale
EP17832350.7A EP3558459A1 (en) 2016-12-22 2017-12-21 Composition for use in the treatment of disorders of the urogenital apparatus
RU2019122801A RU2019122801A (ru) 2016-12-22 2017-12-21 Композиция для применения при лечении нарушения мочеполовой системы
PCT/IB2017/058284 WO2018116238A1 (en) 2016-12-22 2017-12-21 Composition for use in the treatment of disorders of the urogenital apparatus
CN201780086737.1A CN110300616A (zh) 2016-12-22 2017-12-21 用于治疗泌尿生殖器官的病症的组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000130012A IT201600130012A1 (it) 2016-12-22 2016-12-22 Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale

Publications (1)

Publication Number Publication Date
IT201600130012A1 true IT201600130012A1 (it) 2018-06-22

Family

ID=58670171

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000130012A IT201600130012A1 (it) 2016-12-22 2016-12-22 Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale

Country Status (5)

Country Link
EP (1) EP3558459A1 (it)
CN (1) CN110300616A (it)
IT (1) IT201600130012A1 (it)
RU (1) RU2019122801A (it)
WO (1) WO2018116238A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3097436B1 (fr) * 2019-06-24 2023-10-13 Oreal Composition cosmétique comprenant une association d’au moins un oligosaccharide et/ou polysaccharide associé à un monosaccharide mannose
IT201900021483A1 (it) * 2019-11-18 2021-05-18 S I I T S R L Servizio Int Imballaggi Termosaldanti Composizioni comprendenti xiloglucano e D-mannosio e loro uso per il trattamento di disturbi del tratto genito-urinario
CA3161779A1 (en) * 2019-12-19 2021-06-24 An-Katrien VYNCKIER Compositions and methods for managing infections of a urinary tract

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056380A2 (en) * 2002-12-23 2004-07-08 Forum Bioscience Holdings Limited Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
JP2007137797A (ja) * 2005-11-16 2007-06-07 Ss Pharmaceut Co Ltd ウワウルシ乾燥エキス含有経口製剤
WO2007144778A2 (en) * 2006-02-22 2007-12-21 Biologic Health Solutions Pty Ltd. Herbal compositions for the prevention or treatment of a urinary tract infection
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
WO2012123491A1 (en) * 2011-03-15 2012-09-20 Velleja Research S.R.L. Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e
WO2016027226A1 (en) * 2014-08-19 2016-02-25 Kolinpharma S.P.A. A composition for the treatment and prevention of urinary tract infections

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056380A2 (en) * 2002-12-23 2004-07-08 Forum Bioscience Holdings Limited Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
JP2007137797A (ja) * 2005-11-16 2007-06-07 Ss Pharmaceut Co Ltd ウワウルシ乾燥エキス含有経口製剤
WO2007144778A2 (en) * 2006-02-22 2007-12-21 Biologic Health Solutions Pty Ltd. Herbal compositions for the prevention or treatment of a urinary tract infection
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
WO2012123491A1 (en) * 2011-03-15 2012-09-20 Velleja Research S.R.L. Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e
WO2016027226A1 (en) * 2014-08-19 2016-02-25 Kolinpharma S.P.A. A composition for the treatment and prevention of urinary tract infections

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200739, Derwent World Patents Index; AN 2007-409294, XP002772909 *

Also Published As

Publication number Publication date
RU2019122801A3 (it) 2021-03-26
WO2018116238A1 (en) 2018-06-28
RU2019122801A (ru) 2021-01-22
EP3558459A1 (en) 2019-10-30
CN110300616A (zh) 2019-10-01

Similar Documents

Publication Publication Date Title
HUS2400004I1 (hu) Diaminopirimidin-P2X3 és P2X2/3 receptor modulátorok felhasználásra köhögés kezelésében
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
DK2945642T3 (da) Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
IT201600101413A1 (it) Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IL256350A (en) Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders
MA42497A (fr) Procédés et compositions pour la régulation sélective de l'expression protéique
ITUA20162575A1 (it) Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
DK3529234T3 (da) Forbindelser, fremgangsmåde til opnåelse af forbindelserne, farmaceutisk sammensætning, anvendelse af forbindelserne og fremgangsmåde til behandling af psykiatriske lidelser og/eller søvnforstyrrelser
IT201600130012A1 (it) Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
MX371343B (es) Moduladores del receptor x hepatico (lxr).
PH12016501658A1 (en) Sialylated glycoprotein compositions and uses thereof
IT201600122310A1 (it) Composizione per uso nella terapia di alterazioni dell'intestino
IT201700111939A1 (it) Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
ITUB20153759A1 (it) Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo
DK3442537T3 (da) (+)-azasetron til anvendelse i behandlingen af ørelidelser
ITUA20163037A1 (it) Formulazioni per uso nel trattamento o prevenzione di disturbi urologici
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease
IT201700035964A1 (it) “divisorio per boiserie”
ITUA20162343A1 (it) Formulazioni intranasali di bdnf per uso nel trattamento di malattie neurodegenerative